Cargando…
Exploring a four-gene risk model based on doxorubicin resistance-associated lncRNAs in hepatocellular carcinoma
Background: Liver cancer is a lethal cancer type among which hepatocellular carcinoma (HCC) is the most common manifestation globally. Drug resistance is a central problem impeding the efficiency of HCC treatment. Long non-coding RNAs reportedly result in drug resistance. This study aimed to identif...
Autores principales: | Zhang, Zunyi, Chen, Weixun, Luo, Chu, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708384/ https://www.ncbi.nlm.nih.gov/pubmed/36457707 http://dx.doi.org/10.3389/fphar.2022.1015842 |
Ejemplares similares
-
Recurrently deregulated lncRNAs in hepatocellular carcinoma
por: Yang, Yang, et al.
Publicado: (2017) -
The Roles and Mechanisms of lncRNAs in Liver Fibrosis
por: Wang, Zhifa, et al.
Publicado: (2021) -
Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma
por: Wang, Zhonghao, et al.
Publicado: (2017) -
A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma
por: Liao, Le-En, et al.
Publicado: (2020) -
Molecular pattern of lncRNAs in hepatocellular carcinoma
por: Mai, Haoming, et al.
Publicado: (2019)